158 related articles for article (PubMed ID: 38460003)
21. Effects of Chinese herbal medicine in patients with benign prostatic hyperplasia: A nationwide cohort study in Taiwan.
Ou SC; Huang ST; Lin MC; Chen WC; Huang CP; Lin HJ
Int J Urol; 2022 Jul; 29(7):623-630. PubMed ID: 35486019
[TBL] [Abstract][Full Text] [Related]
22. Association between asthma and risk of benign prostatic hyperplasia: a retrospective population-based study.
Peng YH; Huang CW; Chou CY; Chiou HJ; Chen HJ; Wu TN; Ho WC
Aging Male; 2020 Dec; 23(5):599-606. PubMed ID: 30632854
[TBL] [Abstract][Full Text] [Related]
23. [Correlation of IPSS with IL-8 and COX-2 levels in patients with benign prostatic hyperplasia and prostatitis].
Chen DA; Yang XZ; Zhang PH; Li GS; Chang DG
Zhonghua Nan Ke Xue; 2013 Jun; 19(6):527-30. PubMed ID: 23862231
[TBL] [Abstract][Full Text] [Related]
24. Risk of incident benign prostatic hyperplasia in patients with gout: a retrospective cohort study.
Li WM; Pasaribu N; Lee SS; Tsai WC; Li CY; Lin GT; Chuang HY; Tung YC; Tu HP
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):277-286. PubMed ID: 29858589
[TBL] [Abstract][Full Text] [Related]
25. Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.
Shih HJ; Huang CJ; Lin JA; Kao MC; Fan YC; Tsai PS
Prostate; 2018 Feb; 78(2):113-120. PubMed ID: 29119583
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
[TBL] [Abstract][Full Text] [Related]
27. Increased Risk of Incident Disease in Men with Peyronie's Disease: Analysis of U.S. Claims Data.
Pastuszak AW; Rodriguez KM; Solomon ZJ; Kohn TP; Lipshultz LI; Eisenberg ML
J Sex Med; 2018 Jun; 15(6):894-901. PubMed ID: 29803352
[TBL] [Abstract][Full Text] [Related]
28. Cholesterol and benign prostate disease.
Freeman MR; Solomon KR
Differentiation; 2011; 82(4-5):244-52. PubMed ID: 21862201
[TBL] [Abstract][Full Text] [Related]
29. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
[TBL] [Abstract][Full Text] [Related]
30. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
Wu XJ; Yang LY; Zhang XZ
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
[TBL] [Abstract][Full Text] [Related]
31. Chronic prostatitis and depressive disorder: a three year population-based study.
Chung SD; Huang CC; Lin HC
J Affect Disord; 2011 Nov; 134(1-3):404-9. PubMed ID: 21665291
[TBL] [Abstract][Full Text] [Related]
32. Effect of benign prostatic hyperplasia on the development of spine, hip, and wrist fractures.
Yang SC; Chiu YC; Liu PH; Hsieh TJ; Kao YH; Tu YK
Osteoporos Int; 2019 May; 30(5):1043-1049. PubMed ID: 30706096
[TBL] [Abstract][Full Text] [Related]
33. Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.
Tseng CH
BMC Cancer; 2013 Jan; 13():7. PubMed ID: 23286275
[TBL] [Abstract][Full Text] [Related]
34. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
[TBL] [Abstract][Full Text] [Related]
35. Prostate inflammation. Association with benign prostatic hyperplasia and prostate cancer.
Abdel-Meguid TA; Mosli HA; Al-Maghrabi JA
Saudi Med J; 2009 Dec; 30(12):1563-7. PubMed ID: 19936421
[TBL] [Abstract][Full Text] [Related]
36. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of chronic prostatic inflammation based on clinical diagnostic criteria in a real-practice setting: a nation-wide observational study.
Fusco F; Arcaniolo D; Restaino A; Lauri I; Franzese C;
Minerva Urol Nefrol; 2017 Oct; 69(5):509-518. PubMed ID: 28114753
[TBL] [Abstract][Full Text] [Related]
38. The association between prostatitis and risk of prostate cancer: a National Health Insurance Database study.
Jung G; Kim JK; Kim H; Lee J; Hong SK
World J Urol; 2022 Nov; 40(11):2781-2787. PubMed ID: 36201020
[TBL] [Abstract][Full Text] [Related]
39. A case-control study on the association between chronic prostatitis/chronic pelvic pain syndrome and erectile dysfunction.
Chung SD; Keller JJ; Lin HC
BJU Int; 2012 Sep; 110(5):726-30. PubMed ID: 22313519
[TBL] [Abstract][Full Text] [Related]
40. Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
Magri V; Trinchieri A; Montanari E; Del Nero A; Mangiarotti B; Zirpoli P; de Eguileor M; Marras E; Ceriani I; Vral A; Perletti G
Arch Ital Urol Androl; 2007 Jun; 79(2):84-92. PubMed ID: 17695414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
